Prevalence of CVC-associated Sepsis and Use of Blood Cultures in Berlin - Brandenburg
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01388686|
Recruitment Status : Terminated
First Posted : July 7, 2011
Last Update Posted : November 23, 2016
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||13 participants|
|Official Title:||Retrospective Analysis of Proven Bacteremia, CVC-associated Infections and Sepsis|
|Study Start Date :||August 2009|
|Actual Primary Completion Date :||December 2010|
|Actual Study Completion Date :||November 2015|
Participating intensive care units of hospitals in the INABBRA alliance.
- Total number of blood cultures drawn and total number of positive findings in ICUs [ Time Frame: 1 year ]Retrospective analysis of cases with positive bloodculture among patients in ICU setting compared to the total amount of blood cultures taken in the same period of time and same hospital.
- Prevalence on CVC - associated sepsis/CLABSIs [ Time Frame: 1 year ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01388686
|Department of Anesthesiology and Intensive Care Medicine, Campus Virchow-Klinikum and Campus Charité Mitte, Charité - Universitaetsmedizin Berlin|
|Berlin, Germany, 13353|
|Study Director:||Claudia Spies, MD, Prof.||Department of Anesthesiology and Intensive Care Medicine, Campus Virchow-Klinikum and Campus Charité Mitte, Charité - Universitaetsmedizin Berlin|